# Insights for AI Startups' Global Leap

- Link: https://www.venturesquare.net/1097147/
- Discussion: https://startupxo.com/en/568/
- Posted by mrlatte at 2026-07-09T03:04:41.000Z
- 1 point, 0 comments, kind story, origin archive
- Written in ko, machine translated to en

## Summary

- Sixsense and J&P Medi are accelerating their overseas expansion by being selected for Y Combinator's Summer 2026 batch and the Unicorn Bridge program.
- While the schedules for batches and support programs move quickly, the pace at which manufacturing sites and clinical trials are adopted do not move at the same rhythm.
- The variable that can advance the timetable is the speed of collecting data and proving efficiency on site rather than just prior information.
- Participating in the programs should be viewed not as the completion of overseas expansion but as the start of validation.

## Comments (0)

No comments yet.

JSON: https://startupxo.com/api/v1/item.json?id=568&lang=en
